¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"validity of clinical study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
clinical epidemiologist
ÀÓ»ó¿ªÇÐÀÚ
clinical epidemiology
ÀÓ»ó¿ªÇÐ
clinical finding
ÀÓ»ó¼Ò°ß
clinical laboratory
ÀÓ»ó°Ë»ç½Ç
clinical manifestation
ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
clinical material
Àӻ󰡰˹°, ÀÓ»ó°Ëü
clinical medicine
ÀÓ»óÀÇÇÐ
clinical otosclerosis
¹ßÇö±Í°æÈÁõ
clinical pathology
ÀÓ»óº´¸®ÇÐ
clinical record
ÀÓ»ó±â·Ï
clinical root
ÀÓ»óÄ¡¾Æ»Ñ¸®, ÀÓ»óÄ¡±Ù
clinical sign
ÀÓ»ó¡ÈÄ
clinical significance
ÀÓ»óÀûÁ߿伺
clinical skill
ÀÓ»ó¼ú±â
clinical trial
ÀÓ»ó½ÃÇè
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
population study
Àα¸Á¶»ç
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
single blinding study
´Ü¼ø¸Í°Ë¹ý
urodynamic study
¿ä¿ªµ¿Çа˻ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
clinical epidemiologist
ÀÓ»ó¿ªÇÐÀÚ
clinical epidemiology
ÀÓ»ó¿ªÇÐ
clinical finding
ÀÓ»ó¼Ò°ß
clinical laboratory
ÀÓ»ó°Ë»ç½Ç
clinical manifestation
ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
clinical material
Àӻ󰡰˹°, ÀÓ»ó°Ëü
clinical medicine
ÀÓ»óÀÇÇÐ
clinical mycology
ÀÓ»óÁø±ÕÇÐ
clinical otosclerosis
¹ßÇö±Í°æÈÁõ
clinical record
ÀÓ»ó±â·Ï
clinical root
ÀÓ»óÄ¡¾Æ»Ñ¸®
clinical sign
ÀÓ»ó¡ÈÄ
clinical significance
ÀÓ»óÀûÁ߿伺
clinical skill
ÀÓ»ó¼ú±â
clinical specimen
ÀÓ»ó°Ë»ç¹°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
4
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®¿¬±¸
microbiologic study
¹Ì»ý¹°ÇÐÀû °Ë»ç
molecular genetic study
ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
nested case control study
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
retrospective study
ÈÄÇâÀû¿¬±¸
single blind study
´ÜÀÏ<¼ø>¸Í°Ë¹ý.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½